Michael Murphy

1.1k total citations
32 papers, 725 citations indexed

About

Michael Murphy is a scholar working on Pharmacology, Economics and Econometrics and Psychiatry and Mental health. According to data from OpenAlex, Michael Murphy has authored 32 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 7 papers in Economics and Econometrics and 6 papers in Psychiatry and Mental health. Recurrent topics in Michael Murphy's work include Health Systems, Economic Evaluations, Quality of Life (6 papers), Cholinesterase and Neurodegenerative Diseases (5 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers). Michael Murphy is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (6 papers), Cholinesterase and Neurodegenerative Diseases (5 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers). Michael Murphy collaborates with scholars based in United States, United Kingdom and Finland. Michael Murphy's co-authors include John J. Sramek, Neal R. Cutler, Henry Riordan, Paola Antonini, Christopher L. Reading, Clarence Ahlem, Li‐Jung Tseng, Anjan Chatterjee, Dahlia Garza and Flavia Franconi and has published in prestigious journals such as Biological Psychiatry, Annals of the New York Academy of Sciences and Journal of Clinical Epidemiology.

In The Last Decade

Michael Murphy

30 papers receiving 696 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Murphy United States 13 176 174 133 106 89 32 725
Mehala Subramanieapillai Canada 8 161 0.9× 158 0.9× 112 0.8× 88 0.8× 201 2.3× 8 737
Mei‐Chun Hsiao Taiwan 18 87 0.5× 129 0.7× 203 1.5× 84 0.8× 80 0.9× 37 766
Ruth A. Mulnard United States 9 302 1.7× 156 0.9× 259 1.9× 71 0.7× 38 0.4× 17 1.3k
Marek Krzystanek Poland 17 177 1.0× 78 0.4× 131 1.0× 143 1.3× 68 0.8× 110 1.0k
Victoria Marshe Canada 15 115 0.7× 84 0.5× 157 1.2× 110 1.0× 105 1.2× 27 557
Heidi J. Wehring United States 21 217 1.2× 105 0.6× 484 3.6× 126 1.2× 146 1.6× 49 1.2k
John Culberson United States 14 233 1.3× 90 0.5× 90 0.7× 209 2.0× 43 0.5× 28 836
Carina Hibberd United Kingdom 13 116 0.7× 96 0.6× 91 0.7× 61 0.6× 73 0.8× 20 1.2k
Kerri Smith Canada 5 95 0.5× 98 0.6× 91 0.7× 175 1.7× 282 3.2× 11 879
Giuseppe Fanelli Italy 16 108 0.6× 140 0.8× 254 1.9× 96 0.9× 183 2.1× 52 720

Countries citing papers authored by Michael Murphy

Since Specialization
Citations

This map shows the geographic impact of Michael Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Murphy more than expected).

Fields of papers citing papers by Michael Murphy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Murphy. The network helps show where Michael Murphy may publish in the future.

Co-authorship network of co-authors of Michael Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Murphy. A scholar is included among the top collaborators of Michael Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Murphy. Michael Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murphy, Michael, Jun Wang, Lei Wang, et al.. (2023). 37. Electroencephalographic Microstates During Sleep and Wake in Schizophrenia. Biological Psychiatry. 93(9). S84–S84.
2.
Reading, Christopher L., Clarence Ahlem, & Michael Murphy. (2021). NM101 Phase III Study of NE3107 in Alzheimer’s Disease: rationale, Design and Therapeutic Modulation of Neuroinflammation and Insulin Resistance. Neurodegenerative Disease Management. 11(4). 289–298. 54 indexed citations
3.
Sramek, John J., et al.. (2017). Lurasidone in post-menopausal females with major depressive disorder with mixed features: Post-hoc analysis of a placebo-controlled trial. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 78. 12–17. 7 indexed citations
4.
Sramek, John J., Michael Murphy, & Neal R. Cutler. (2016). Sex differences in the psychopharmacological treatment of depression. Dialogues in Clinical Neuroscience. 18(4). 447–457. 220 indexed citations
5.
Kahan, Brennan C, Caroline J Doré, Michael Murphy, & Vipul Jairath. (2016). Bias was reduced in an open-label trial through the removal of subjective elements from the outcome definition. Journal of Clinical Epidemiology. 77. 38–43. 6 indexed citations
6.
Beelke, Manolo, Paola Antonini, & Michael Murphy. (2016). Evolving landscapes in multiple sclerosis research: adaptive designs and novel endpoints. 1(1). 1 indexed citations
7.
Murphy, Michael. (2013). The intergenerational transmission of reproductive behaviour: comparative perspectives. The History of the Family. 18(2). 107–115. 10 indexed citations
8.
Rinne, Juha O., et al.. (2013). Safety and efficacy of ORM-12741 on cognitive and behavioral symptoms in patients with Alzheimer's disease: A randomized, double-blind, proof-of-concept study. Journal of the Neurological Sciences. 333. e322–e322. 9 indexed citations
9.
Martikainen, Pekka, Heta Moustgaard, Elina Einiö, & Michael Murphy. (2013). Life Expectancy in Long-Term Institutional Care by Marital Status: Multistate Life Table Estimates for Older Finnish Men and Women. The Journals of Gerontology Series B. 69(2). 303–310. 21 indexed citations
10.
Egan, Michael, Xin Zhao, Matthew D. Troyer, et al.. (2013). Randomized controlled study of the T‐type calcium channel antagonist MK‐8998 for the treatment of acute psychosis in patients with schizophrenia. Human Psychopharmacology Clinical and Experimental. 28(2). 124–133. 32 indexed citations
11.
Franconi, Flavia, et al.. (2012). Sex and Gender in Adverse Drug Events, Addiction, and Placebo. Handbook of experimental pharmacology. 107–126. 35 indexed citations
12.
Dubois, Bruno, Mohammed Zaïm, Jacques Touchon, et al.. (2012). Effect of Six Months of Treatment with V0191 in Patients with Suspected Prodromal Alzheimer's Disease. Journal of Alzheimer s Disease. 29(3). 527–535. 7 indexed citations
13.
Murphy, Michael. (2010). Pharmacogenomics and drug development.. PubMed. 3(2). 79–80. 1 indexed citations
14.
15.
16.
Ivanova, Anastasia & Michael Murphy. (2009). An Adaptive First in Man Dose-Escalation Study of NGX267: Statistical, Clinical, and Operational Considerations. Journal of Biopharmaceutical Statistics. 19(2). 247–255. 8 indexed citations
17.
Greenberg, Barry & Michael Murphy. (1994). Toward an integrated discovery and development program in Alzheimer's disease: The amyloid hypothesis. Neurobiology of Aging. 15. 105–109. 5 indexed citations
18.
Cutler, Neal R., John J. Sramek, Michael Murphy, & Robert J. Nash. (1992). Implications of the Study Population in the Early Evaluation of Anticholinesterase Inhibitors for Alzheimer's Disease. Annals of Pharmacotherapy. 26(9). 1118–1122. 11 indexed citations
19.
Murphy, Michael, et al.. (1991). Evaluation of HP 029 (Velnacrine Maleate) in Alzheimer's Diseasea. Annals of the New York Academy of Sciences. 640(1). 253–262. 37 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mehala Subramanieapillai Breakdown of academic impact, for papers by Mei‐Chun Hsiao Breakdown of academic impact, for papers by Ruth A. Mulnard Breakdown of academic impact, for papers by Marek Krzystanek Breakdown of academic impact, for papers by Victoria Marshe Breakdown of academic impact, for papers by Heidi J. Wehring Breakdown of academic impact, for papers by John Culberson Breakdown of academic impact, for papers by Carina Hibberd Breakdown of academic impact, for papers by Kerri Smith Breakdown of academic impact, for papers by Giuseppe Fanelli
Rankless by CCL
2026